Mrs. Lynne M. Edebohls, APNP Nurse Practitioner - Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1025 Mulberry St, Lake Mills, WI 53551 Phone: 920-648-4518 Fax: 920-648-1623 |
Nicole Lee Berg-johnson, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 125 E Pine St Ste C, Lake Mills, WI 53551 Phone: 920-648-5271 Fax: 920-648-4365 |
Katherine A Lothe, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1025 Mulberry St, Lake Mills, WI 53551 Phone: 920-648-4518 Fax: 920-648-1623 |
Dr. Ruthanne Reichert Taylor, FNP-BC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: N6973 Rock Lake Rd Apt 26, Lake Mills, WI 53551 Phone: 307-203-6813 |
Bridget A. Halbersma, NP,APNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 200 E Tyranena Park Rd, Lake Mills, WI 53551 Phone: 920-648-8393 |
Mckenna Meihak, APNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 200 E Tyranena Park Rd, Lake Mills, WI 53551 Phone: 920-648-8393 |
News Archive
A new therapeutic agent tested in a mouse model of multiple sclerosis (MS) produced anti-inflammatory activity and prevented loss of cells in the optic nerve, according to a new study by researchers in the Perelman School of Medicine at the University of Pennsylvania, with Pittsburgh-based Noveome Biotherapeutics.
LABS, Inc., a global, full-service testing laboratory with more than 30 years of expertise in regulated testing for human organs, cells, tissues and implantable biologic products and devices, today announced that it has been granted AABB Accreditation for donor testing.
Ground-breaking research results about stress during pregnancy and changes in pollen potency across Europe will be presented - among other novel research - at the world's leading congress on allergy and immunology - the EAACI Congress 2012 - that will open tomorrow in Geneva, Switzerland.
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Stephen M. Simes, its president and CEO will present an overview of the company and its impending merger with Cell Genesys (NASDAQ: CEGE) at two healthcare investment and partnering conferences during the month of September.
› Verified 2 days ago